Diagnosis and treatment of tick infestation and tick-borne diseases with cutaneous manifestations

Dermatologic Therapy

Volumn 22, Issue 4, 2009, Pages 293-326

  Dana, Ali N ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Johns Hopkins Outpatient Center   (United States)

Author keywords

Arthropod; Babesia; Borrelia; Ehrlichia; Flaviviruses; Rickettsia; Tick; Tularemia; Vector borne

Indexed keywords

AMOXICILLIN; ATOVAQUONE; AZITHROMYCIN; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; PENICILLIN V; QUININE; RIBAVIRIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

ANAPLASMOSIS; ARTHROPOD; BABESIOSIS; BACTERIAL INFECTION; BORRELIA INFECTION; EHRLICHIOSIS; HEMORRHAGIC FEVER; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; INFECTION; INFESTATION; INFLAMMATION; LOADING DRUG DOSE; MIXED INFECTION; MORBIDITY; PARASITE VECTOR; PROTOZOAL INFECTION; REVIEW; RICKETTSIACEAE INFECTION; RICKETTSIOSIS; SKIN MANIFESTATION; TICK BITE; TICK BORNE DISEASE; TICK BORNE ENCEPHALITIS; TULAREMIA; TYPHUS; VIRUS INFECTION;

ANIMALS; DISEASE VECTORS; HUMANS; SKIN DISEASES; TICK-BORNE DISEASES; TICKS;

EID: 67650763299     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2009.01244.x     Document Type: Review

References (239)

1. Anderson JF, Magnarelli LA. Biology of ticks. Infect Dis Clin North Am 2008 : 22 : 195 215, v. (Pubitemid 351608539)
2. Vanousova D, Hercogova J. Lyme borreliosis treatment. Dermatol Ther 2008 : 21 : 101 109.
3. McGinley-Smith DE, Tsao SS. Dermatoses from ticks. J Am Acad Dermatol 2003 : 49 : 363 392 : quiz 393-366. (Pubitemid 37051898)
4. Edlow JA, McGillicuddy DC. Tick paralysis. Infect Dis Clin North Am 2008 : 22 : 397 413, vii.
5. Brown AF, Hamilton DL. Tick bite anaphylaxis in Australia. J Accid Emerg Med 1998 : 15 : 111 113.
6. Dworkin MS, Shoemaker PC, Anderson DE. Tick paralysis: 33 human cases in Washington State, 1946-1996. Clin Infect Dis 1999 : 29 : 1435 1439. (Pubitemid 30022737)
7. Stone BF, Commins MA, Kemp DH. Artificial feeding of the Australian paralysis tick, Ixodes holocyclus and collection of paralysing toxin. Int J Parasitol 1983 : 13 : 447 454. (Pubitemid 14243187)
8. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE Jr., Fritsche TR. Tick-borne diseases in the United States. N Engl J Med 1993 : 329 : 936 947. (Pubitemid 23275277)
9. Felz MW, Smith CD, Swift TR. A six-year-old girl with tick paralysis. N Engl J Med 2000 : 342 : 90 94. (Pubitemid 30036600)
10. Centers for Disease Control and Prevention. Cluster of tick paralysis cases-Colorado, 2006. MMWR Morb Mortal Wkly Rep 2006 : 55 : 933 935.
11. Centers for Disease Control and Prevention. Tick paralysis-Wisconsin. MMWR Morb Mortal Wkly Rep 1981 : 30 : 217 218.
12. Gauci M, Loh RK, Stone BF, Thong YH. Allergic reactions to the Australian paralysis tick, Ixodes holocyclus: diagnostic evaluation by skin test and radioimmunoassay. Clin Exp Allergy 1989 : 19 : 279 283. (Pubitemid 19147913)
13. Bode D, Speicher P, Harlan H. A seed tick infestation of the conjunctiva: Amblyomma americanum larva. Ann Ophthalmol 1987 : 19 : 63 64. (Pubitemid 17020797)
14. Duckworth PF, Jr., Hayden GF, Reed CN. Human infestation by Amblyomma americanum larvae ("seed ticks"). South Med J 1985 : 78 : 751 753. (Pubitemid 15024312)
15. Jones BE. Human "seed tick" infestation. Amblyomma americanum larvae. Arch Dermatol 1981 : 117 : 812 814.
16. Fisher EJ, Mo J, Lucky AW. Multiple pruritic papules from lone star tick larvae bites. Arch Dermatol 2006 : 142 : 491 494. (Pubitemid 43671650)
17. Nduaka O, Ikeme MM. Human skin lesions in East Central State, Nigeria, due to the larvae of Amblyomma variegatum (Fabricius, 1794). Niger Med J 1973 : 3 : 140 143.
18. Fibeger EA, Erickson QL, Weintraub BD, Elston DM. Larval tick infestation: a case report and review of tick-borne disease. Cutis 2008 : 82 : 38 46.
19. Elston DM. Human infestation by larval Amblyomma ticks. Arch Dermatol 2006 : 142 : 497 500. (Pubitemid 43671651)
20. Stewart RL, Burgdorfer W, Needham GR. Evaluation of three commercial tick removal tools. Wilderness Environ Med 1998 : 9 : 137 142. (Pubitemid 28548784)
21. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994 : 120 : 736 743. (Pubitemid 24125293)
22. McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States. Emerg Infect Dis 1999 : 5 : 635 642. (Pubitemid 29493765)
23. Paddock CD, Childs JE. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev 2003 : 16 : 37 64. (Pubitemid 36118845)
24. Paddock CD, Folk SM, Shore GM. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 2001 : 33 : 1586 1594. (Pubitemid 34246156)
25. Edwards MS. Human ehrlichiosis. Adv Pediatr Infect Dis 1991 : 6 : 163 178.
26. Harkess JR. Ehrlichiosis. Infect Dis Clin North Am 1991 : 5 : 37 51.
27. Everett ED, Evans KA, Henry RB, McDonald G. Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994 : 120 : 730 735. (Pubitemid 24125292)
28. Childs JE, Sumner JW, Nicholson WL, Massung RF, Standaert SM, Paddock CD. Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 1999 : 37 : 2997 3000. (Pubitemid 29391924)
29. Walker DH. Diagnosing human ehrlichioses: current status and recommendations. Am Soc Microbiol News 2000 : 66 : 287 291.
30. Nadelman RB, Horowitz HW, Hsieh TC, Wu JM, Aguero-Rosenfeld ME, Schwartz I, Nowakowski J, Varde S, Wormser GP. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997 : 337 : 27 30. (Pubitemid 27290844)
31. Bakken JS, Krueth JK, Lund T, Malkovitch D, Asanovich K, Dumler JS. Exposure to deer blood may be a cause of human granulocytic ehrlichiosis. Clin Infect Dis 1996 : 23 : 198. (Pubitemid 26323830)
32. Bakken JS, Dumler JS. Human granulocytic ehrlichiosis. Clin Infect Dis 2000 : 31 : 554 560. (Pubitemid 32289590)
33. Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987 : 316 : 853 856. (Pubitemid 17042004)
34. Brouqui P, Raoult D. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob Agents Chemother 1992 : 36 : 2799 2803.
35. Maurin M, Bakken JS, Dumler JS. Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother 2003 : 47 : 413 415. (Pubitemid 36074933)
36. Dumler JS, Madigan JE, Pusterla N, Bakken JS. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 2007 : 45 (Suppl 1 S45 51.
37. Smilack JD. The tetracyclines. Mayo Clin Proc 1999 : 74 : 727 729. (Pubitemid 29321290)
38. Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001 : 24 : 553 565. (Pubitemid 32595766)
39. Dhand A, Nadelman RB, Aguero-Rosenfeld M, Haddad FA, Stokes DP, Horowitz HW. Human granulocytic anaplasmosis during pregnancy: case series and literature review. Clin Infect Dis 2007 : 45 : 589 593. (Pubitemid 47328639)
40. Buitrago MI, Ijdo JW, Rinaudo P, et al. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis 1998 : 27 : 213 215. (Pubitemid 28334446)
41. Krause PJ, Corrow CL, Bakken JS. Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics 2003 : 112 : e252 253.
42. Wormser GP, Filozov A, Telford SR III. et al. Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis. Vector Borne Zoonotic Dis 2006 : 6 : 388 394. (Pubitemid 46157521)
43. Maurin M, Abergel C, Raoult D. DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp. Antimicrob Agents Chemother 2001 : 45 : 2098 2105. (Pubitemid 32591704)
44. Klein MB, Nelson CM, Goodman JL. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother 1997 : 41 : 76 79. (Pubitemid 26428136)
45. Weinstein RS. Human ehrlichiosis. Am Fam Physician 1996 : 54 : 1971 1976. (Pubitemid 26380320)
46. Homer MJ, Aguilar-Delfin I, Telford SR III., Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev 2000 : 13 : 451 469. (Pubitemid 30452617)
47. Herwaldt B, Persing DH, Precigout EA, et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996 : 124 : 643 650. (Pubitemid 26103838)
48. Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington State: a new species of Babesia? Ann Intern Med 1993 : 119 : 284 290. (Pubitemid 23319885)
49. Conrad PA, Kjemtrup AM, Carreno RA, et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol 2006 : 36 : 779 789. (Pubitemid 43866080)
50. Dammin GJ, Spielman A, Benach JL, Piesman J. The rising incidence of clinical Babesia microti infection. Hum Pathol 1981 : 12 : 398 400. (Pubitemid 11057619)
51. Steketee RW, Eckman MR, Burgess EC, et al. Babesiosis in Wisconsin. A new focus of disease transmission. JAMA 1985 : 253 : 2675 2678. (Pubitemid 15033051)
52. Boustani MR, Gelfand JA. Babesiosis. Clin Infect Dis 1996 : 22 : 611 615. (Pubitemid 26286303)
53. Herwaldt BL, McGovern PC, Gerwel MP, Easton RM, MacGregor RR. Endemic babesiosis in another eastern state: New Jersey. Emerg Infect Dis 2003 : 9 : 184 188. (Pubitemid 36231788)
54. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis 1992 : 15 : 1019 1023.
55. Krause PJ. Babesiosis. Med Clin North Am 2002 : 86 : 361 373. (Pubitemid 34327092)
56. Krause PJ, Gewurz BE, Hill D, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis 2008 : 46 : 370 376. (Pubitemid 351263520)
57. Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001 : 32 : 1117 1125. (Pubitemid 32381117)
58. Chisholm ES, Ruebush TK II., Sulzer AJ, Healy GR. Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg 1978 : 27 : 14 19. (Pubitemid 8269664)
59. Persing DH, Mathiesen D, Marshall WF, et al. Detectionof Babesia microti by polymerase chain reaction. J Clin Microbiol 1992 : 30 : 2097 2103.
60. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006 : 43 : 1089 1134. (Pubitemid 44637131)
61. Weiss LM, Wittner M, Wasserman S, Oz HS, Retsema J, Tanowitz HB. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J Infect Dis 1993 : 168 : 1289 1292. (Pubitemid 23317153)
62. Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 2000 : 343 : 1454 1458. (Pubitemid 30832881)
63. Vial HJ, Gorenflot A. Chemotherapy against babesiosis. Vet Parasitol 2006 : 138 : 147 160. (Pubitemid 44275261)
64. Fox LM, Wingerter S, Ahmed A, et al. Neonatal babesiosis: case report and review of the literature. Pediatr Infect Dis J 2006 : 25 : 169 173. (Pubitemid 43208575)
65. Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol 2008 : 38 : 1219 1237.
66. Francioli PB, Keithly JS, Jones TC, Brandstetter RD, Wolf DJ. Response of babesiosis to pentamidine therapy. Ann Intern Med 1981 : 94 : 326 330. (Pubitemid 11137071)
67. Raoult D, Soulayrol L, Toga B, Dumon H, Casanova P. Babesiosis, pentamidine, and cotrimoxazole. Ann Intern Med 1987 : 107 : 944.
68. Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin Microbiol Rev 2003 : 16 : 622 636. (Pubitemid 37303912)
69. Marley SE, Eberhard ML, Steurer FJ, Ellis WL, McGreevy PB, Ruebush TK II. Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model. Antimicrob Agents Chemother 1997 : 41 : 91 94. (Pubitemid 26428139)
70. Jacoby GA, Hunt JV, Kosinski KS, et al. Treatment of transfusion- transmitted babesiosis by exchange transfusion. N Engl J Med 1980 : 303 : 1098 1100. (Pubitemid 10029971)
71. Evenson DA, Perry E, Kloster B, Hurley R, Stroncek DF. Therapeutic apheresis for babesiosis. J Clin Apher 1998 : 13 : 32 36. (Pubitemid 28215139)
72. Grima KM. Therapeutic apheresis in hematological and oncological diseases. J Clin Apher 2000 : 15 : 28 52. (Pubitemid 30176813)
73. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol 2000 : 30 : 1323 1337. (Pubitemid 30952943)
74. Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis 1996 : 22 : 809 812. (Pubitemid 26255599)
75. Ong KR, Stavropoulos C, Inada Y. Babesiosis, asplenia, and AIDS. Lancet 1990 : 336 : 112. (Pubitemid 20222832)
76. Vyas JM, Telford SR, Robbins GK. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report. Clin Infect Dis 2007 : 45 : 1588 1590.
77. Parola P, Raoult D. Tick-borne bacterial diseases emerging in Europe. Clin Microbiol Infect 2001 : 7 : 80 83. (Pubitemid 34960276)
78. Amsden JR, Warmack S, Gubbins PO. Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review. Pharmacotherapy 2005 : 25 : 191 210. (Pubitemid 40223481)
79. Evans ME, Gregory DW, Schaffner W, McGee ZA. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985 : 64 : 251 269. (Pubitemid 16247108)
80. Choi E. Tularemia and Q fever. Med Clin North Am 2002 : 86 : 393 416. (Pubitemid 34327094)
81. Craven RB, Barnes AM. Plague and tularemia. Infect Dis Clin North Am 1991 : 5 : 165 175.
82. Schmid GP, Kornblatt AN, Connors CA, et al. Clinically mild tularemia associated with tick-borne Francisella tularensis. J Infect Dis 1983 : 148 : 63 67.
83. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994 : 19 : 42 47. (Pubitemid 24227033)
84. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001 : 285 : 2763 2773. (Pubitemid 32525374)
85. Lovell VM, Cho CT, Lindsey NJ, Nelson PL. Francisella tularensis meningitis: a rare clinical entity. J Infect Dis 1986 : 154 : 916 918. (Pubitemid 17181624)
86. Perez-Castrillon JL, Bachiller-Luque P, Martin-Luquero M, Mena-Martin FJ, Herreros V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis 2001 : 33 : 573 576. (Pubitemid 32709594)
87. Limaye AP, Hooper CJ. Treatment of tularemia with fluoroquinolones: two cases and review. Clin Infect Dis 1999 : 29 : 922 924. (Pubitemid 30256390)
88. Risi GF, Pombo DJ. Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis 1995 : 20 : 174 175.
89. Cross JT, Jacobs RF. Tularemia: treatment failures with outpatient use of ceftriaxone. Clin Infect Dis 1993 : 17 : 976 980. (Pubitemid 23358740)
90. Maurin M, Mersali NF, Raoult D. Bactericidal activities of antibiotics against intracellular Francisella tularensis. Antimicrob Agents Chemother 2000 : 44 : 3428 3431. (Pubitemid 33009505)
91. Dworkin MS, Schwan TG, Anderson DE, Jr. Tick-borne relapsing fever in North America. Med Clin North Am 2002 : 86 : 417 433, viii ix. (Pubitemid 34327095)
92. Dworkin MS, Schwan TG, Anderson DE, Jr., Borchardt SM. Tick-borne relapsing fever. Infect Dis Clin North Am 2008 : 22 : 449 468, viii.
93. Hinnebusch BJ, Barbour AG, Restrepo BI, Schwan TG. Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins. Infect Immun 1998 : 66 : 432 440. (Pubitemid 28074177)
94. Dennis DT, Hayes EB. Relapsing fever. In : Braunwald E, Hauser SL Fauci AS, eds. Harrison's Principles of Internal Medicine. New York, NY : McGraw-Hill, 2005 : 991 995.
95. Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998 : 26 : 151 164. (Pubitemid 28068170)
96. Dworkin MS, Anderson DE, Jr., Schwan TG, et al. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis 1998 : 26 : 122 131. (Pubitemid 28068165)
97. Negussie Y, Remick DG, DeForge LE, Kunkel SL, Eynon A, Griffin GE. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J Exp Med 1992 : 175 : 1207 1212.
98. Griffin GE. Cytokines involved in human septic shock-the model of the Jarisch-Herxheimer reaction. J Antimicrob Chemother 1998 : 41 (Suppl A 25 29. (Pubitemid 28062141)
99. Armstrong PM, Rich SM, Smith RD, Hartl DL, Spielman A, Telford SR III. A new Borrelia infecting Lone Star ticks. Lancet 1996 : 347 : 67 68. (Pubitemid 26012439)
100. Barbour AG, Maupin GO, Teltow GJ, Carter CJ, Piesman J. Identification of an uncultivable Borrelia species in the hard tick Amblyomma americanum: possible agent of a Lyme disease-like illness. J Infect Dis 1996 : 173 : 403 409. (Pubitemid 26042441)
101. James AM, Liveris D, Wormser GP, Schwartz I, Montecalvo MA, Johnson BJ. Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis 2001 : 183 : 1810 1814. (Pubitemid 32523246)
102. Moore VAt, Varela AS, Yabsley MJ, Davidson WR, Little SE. Detection of Borrelia lonestari, putative agent of southern tick-associated rash illness, in white-tailed deer (Odocoileus virginianus) from the southeastern United States. J Clin Microbiol 2003 : 41 : 424 427. (Pubitemid 36098611)
103. Masters EJ, Grigery CN, Masters RW. STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness. Infect Dis Clin North Am 2008 : 22 : 361 376, viii. (Pubitemid 351608544)
104. Felz MW, Chandler FW Jr., Oliver JH Jr., Rahn DW, Schriefer ME. Solitary erythema migrans in Georgia and South Carolina. Arch Dermatol 1999 : 135 : 1317 1326.
105. Masters EJ, Girardeau C. Erythema migrans in the South. Arch Intern Med 1998 : 158 : 2162 2165. (Pubitemid 28482102)
106. Charrel RN, Attoui H, Butenko AM, et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 2004 : 10 : 1040 1055. (Pubitemid 40044976)
107. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979 : 15 : 307 417.
108. Tignor GH, Hanham CA. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res 1993 : 22 : 309 325.
109. Watts DM, Ussery MA, Nash D, Peters CJ. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg 1989 : 41 : 581 585. (Pubitemid 20000631)
110. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 1995 : 346 : 472 475.
111. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis 2003 : 36 : 1613 1618. (Pubitemid 36783348)
112. Paragas J, Whitehouse CA, Endy TP, Bray M. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res 2004 : 62 : 21 25. (Pubitemid 38340744)
113. Andersson I, Bladh L, Mousavi-Jazi M, et al. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 2004 : 78 : 4323 4329. (Pubitemid 38437235)
114. Andersson I, Lundkvist A, Haller O, Mirazimi A. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 2006 : 78 : 216 222. (Pubitemid 43132566)
115. Attoui H, Mohd Jaafar F, de Micco P, de Lamballerie X. Coltiviruses and seadornaviruses in North America, Europe, and Asia. Emerg Infect Dis 2005 : 11 : 1673 1679. (Pubitemid 41628344)
116. Leiby DA, Gill JE. Transfusion-transmitted tick-borne infections: a cornucopia of threats. Transfus Med Rev 2004 : 18 : 293 306. (Pubitemid 39402980)
117. Romero JR, Simonsen KA. Powassan encephalitis and colorado tick fever. Infect Dis Clin North Am 2008 : 22 : 545 559, x.
118. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994 : 7 : 89 116. (Pubitemid 24038091)
119. Hughes LE, Casper EA, Clifford CM. Persistence of Colorado tick fever virus in red blood cells. Am J Trop Med Hyg 1974 : 23 : 530 532.
120. Attoui H, Billoir F, Bruey JM, de Micco P, de Lamballerie X. Serologic and molecular diagnosis of Colorado tick fever viral infections. Am J Trop Med Hyg 1998 : 59 : 763 768. (Pubitemid 28524534)
121. Attoui H, Mohd Jaafar F, Biagini P, et al. Genus Coltivirus (family Reoviridae): genomic and morphologic characterization of Old World and New World viruses. Arch Virol 2002 : 147 : 533 561. (Pubitemid 34179627)
122. Smee DF, Sidwell RW, Clark SM, Barnett BB, Spendlove RS. Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances. Antimicrob Agents Chemother 1981 : 20 : 533 538. (Pubitemid 12239270)
123. Suss J. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 2003 : 21 (Suppl 1 S19 35.
124. Kunz C, Heinz FX. Tick-borne encephalitis. Vaccine 2003 : 21 (Suppl 1 S1 2.
125. Gunther G, Haglund M, Lindquist L, Forsgren M, Skoldenberg B. Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome. J Neurol 1997 : 244 : 230 238. (Pubitemid 27156472)
126. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain 1999 : 122 (Pt 11 2067 2078.
127. Haglund M, Gunther G. Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 2003 : 21 (Suppl 1 S11 18.
128. Centers for Disease Control and Prevention. Arboviral disease-United States, 1994. MMWR Morb Mortal Wkly Rep 1995 : 44 : 641 644.
129. Centers for Disease Control and Prevention. Outbreak of Powassan encephalitis-Maine and Vermont, 1999-2001. MMWR Morb Mortal Wkly Rep 2001 : 50 : 761 764.
130. Gholam BI, Puksa S, Provias JP. Powassan encephalitis: a case report with neuropathology and literature review. CMAJ 1999 : 161 : 1419 1422.
131. Zanotto PM, Gao GF, Gritsun T, et al. An arbovirus cline across the northern hemisphere. Virology 1995 : 210 : 152 159.
132. Cooper WC, Green IJ, Fresh JW. Laboratory infection with louping-ill virus: a case study. Br Med J 1964 : 2 : 1627 1630.
133. Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antiviral Res 2003 : 57 : 129 146. (Pubitemid 36254727)
134. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008 : 371 : 500 509. (Pubitemid 351199886)
135. Gritsun TS, Nuttall PA, Gould EA. Tick-borne flaviviruses. Adv Virus Res 2003 : 61 : 317 371. (Pubitemid 137639390)
136. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 2003 : 58 : 73 79. (Pubitemid 36507224)
137. Rendi-Wagner P. Advances in vaccination against tick-borne encephalitis. Expert Rev Vaccines 2008 : 7 : 589 596. (Pubitemid 351881343)
138. Waldvogel K, Bossart W, Huisman T, Boltshauser E, Nadal D. Severe tick-borne encephalitis following passive immunization. Eur J Pediatr 1996 : 155 : 775 779. (Pubitemid 26261870)
139. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 2005 : 18 : 719 756. (Pubitemid 41504513)
140. Sexton DJ, Kaye KS. Rocky mountain spotted fever. Med Clin North Am 2002 : 86 : 351 360, vii viii. (Pubitemid 34327091)
141. Fishbein DB, Kaplan JE, Bernard KW, Winkler WG. Surveillance of Rocky Mountain spotted fever in the United States, 1981-1983. J Infect Dis 1984 : 150 : 609 611. (Pubitemid 14013984)
142. Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006 : 55 : 1 27.
143. Oster CN, Burke DS, Kenyon RH, Ascher MS, Harber P, Pedersen CE Jr. Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med 1977 : 297 : 859 863. (Pubitemid 8200497)
144. Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs JE. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 2000 : 63 : 21 26. (Pubitemid 32423090)
145. Chen LF, Sexton DJ. What's new in Rocky Mountain spotted fever? Infect Dis Clin North Am 2008 : 22 : 415 432, vii viii.
146. Raoult D, Drancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother 1991 : 35 : 2457 2462.
147. Wisseman CL, Waddell A. In vitro sensitivity of Rickettsia rickettsii to doxycycline. J Infect Dis 1982 : 145 : 584.
148. Wisseman CL Jr., Ordonez SV. Actions of antibiotics on Rickettsia rickettsii. J Infect Dis 1986 : 153 : 626 628. (Pubitemid 16135673)
149. Breitschwerdt EB, Papich MG, Hegarty BC, Gilger B, Hancock SI, Davidson MG. Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob Agents Chemother 1999 : 43 : 813 821. (Pubitemid 29165744)
150. Breitschwerdt EB, Davidson MG, Aucoin DP, Levy MG, Szabados NS, Hegarty BC, Kuehne AL, James RL. Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob Agents Chemother 1991 : 35 : 2375 2381.
151. Lochary ME, Lockhart PB, Williams WT Jr. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 1998 : 17 : 429 431. (Pubitemid 28232872)
152. Lacz NL, Schwartz RA, Kapila R. Rocky Mountain spotted fever. J Eur Acad Dermatol Venereol 2006 : 20 : 411 417.
153. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, Childs JE. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995 : 52 : 405 413.
154. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001 : 184 : 1437 1444. (Pubitemid 33108858)
155. Silber JL. Rocky Mountain spotted fever. Clin Dermatol 1996 : 14 : 245 258. (Pubitemid 26159835)
156. Paddock CD, Sumner JW, Comer JA, et al. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis 2004 : 38 : 805 811. (Pubitemid 38387226)
157. Goddard J. Experimental infection of lone star ticks, Amblyomma americanum (L.), with Rickettsia parkeri and exposure of guinea pigs to the agent. J Med Entomol 2003 : 40 : 686 689. (Pubitemid 37399543)
158. Venzal JM, Portillo A, Estrada-Pena A, Castro O, Cabrera PA, Oteo JA. Rickettsia parkeri in Amblyomma triste from Uruguay. Emerg Infect Dis 2004 : 10 : 1493 1495. (Pubitemid 39014170)
159. Whitman TJ, Richards AL, Paddock CD, et al. Rickettsia parkeri infection after tick bite, Virginia. Emerg Infect Dis 2007 : 13 : 334 336. (Pubitemid 46193188)
160. Zhu Y, Fournier PE, Eremeeva M, Raoult D. Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence typing and an emended description of Rickettsia conorii. BMC Microbiol 2005 : 5 : 11.
161. Rovery C, Raoult D. Mediterranean spotted fever. Infect Dis Clin North Am 2008 : 22 : 515 530, ix.
162. Bella-Cueto F, Font-Creus B, Segura-Porta F, Espejo-Arenas E, Lopez-Pares P, Munoz-Espin T. Comparative, randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. J Infect Dis 1987 : 155 : 1056 1058. (Pubitemid 17062851)
163. Munoz-Espin T, Lopez-Pares P, Espejo-Arenas E, et al. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch Dis Child 1986 : 61 : 1027 1029. (Pubitemid 16033409)
164. Raoult D, Roussellier P, Vestris G, Tamalet J. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J Infect Dis 1987 : 155 : 1059 1062. (Pubitemid 17062852)
165. Bella F, Font B, Uriz S, Munoz T, Espejo E, Traveria J, Serrano JA, Segura F. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever. Antimicrob Agents Chemother 1990 : 34 : 937 938. (Pubitemid 20142434)
166. Dzelalija B, Petrovec M, Avsic-Zupanc T, Strugar J, Milic TA. Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever. Acta Med Croatica 2002 : 56 : 45 47. (Pubitemid 36105409)
167. Cascio A, Colomba C, Antinori S, Paterson DL, Titone L. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis 2002 : 34 : 154 158. (Pubitemid 34028345)
168. Raoult D, Roussellier P, Galicher V, Perez R, Tamalet J. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob Agents Chemother 1986 : 29 : 424 425. (Pubitemid 16143248)
169. Ruiz Beltran R, Herrero Herrero JI. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis 1992 : 11 : 427 431.
170. Gudiol F, Pallares R, Carratala J, Bolao F, Ariza J, Rufi G, Viladrich PF. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob Agents Chemother 1989 : 33 : 987 988. (Pubitemid 19146601)
171. Bella F, Espejo E, Uriz S, Serrano JA, Alegre MD, Tort J. Randomized trial of 5-day rifampin versus 1-day doxycycline therapy for Mediterranean spotted fever. J Infect Dis 1991 : 164 : 433 434.
172. Ruiz Beltran R, Herrero Herrero JI. Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever. Antimicrob Agents Chemother 1992 : 36 : 1342 1343.
173. Kelly PJ, Beati L, Mason PR, Matthewman LA, Roux V, Raoult D. Rickettsia africae sp. nov., the etiological agent of African tick bite fever. Int J Syst Bacteriol 1996 : 46 : 611 614. (Pubitemid 26113894)
174. Jensenius M, Fournier PE, Kelly P, Myrvang B, Raoult D. African tick bite fever. Lancet Infect Dis 2003 : 3 : 557 564. (Pubitemid 37064535)
175. Raoult D, Fournier PE, Fenollar F, et al. Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001 : 344 : 1504 1510. (Pubitemid 32429209)
176. Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997 : 10 : 694 719. (Pubitemid 27477731)
177. Roux V, Fournier PE, Raoult D. Differentiation of spotted fever group rickettsiae by sequencing and analysis of restriction fragment length polymorphism of PCR-amplified DNA of the gene encoding the protein rOmpA. J Clin Microbiol 1996 : 34 : 2058 2065.
178. Jensenius M, Fournier PE, Vene S, et al. African tick bite fever in travelers to rural sub-Equatorial Africa. Clin Infect Dis 2003 : 36 : 1411 1417. (Pubitemid 36702875)
179. Toutous-Trellu L, Peter O, Chavaz P, Saurat JH. African tick bite fever:
180. Mahara F. Japanese spotted fever: report of 31 cases and review of the literature. Emerg Infect Dis 1997 : 3 : 105 111. (Pubitemid 127431668)
181. Kaplan LI. Other spotted fevers. Clin Dermatol 1996 : 14 : 259 267. (Pubitemid 26159836)
182. Mahara F. Rickettsioses in Japan and the far East. Ann N Y Acad Sci 2006 : 1078 : 60 73. (Pubitemid 44968591)
183. Seki M, Ikari N, Yamamoto S, et al. Severe Japanese spotted fever successfully treated with fluoroquinolone. Intern Med 2006 : 45 : 1323 1326. (Pubitemid 44942093)
184. Mediannikov OY, Sidelnikov Y, Ivanov L, et al. Acute tick-borne rickettsiosis caused by Rickettsia heilongjiangensis in Russian Far East. Emerg Infect Dis 2004 : 10 : 810 817. (Pubitemid 38552747)
185. Graves S, Stenos J. Rickettsia honei: a spotted fever group Rickettsia on three continents. Ann N Y Acad Sci 2003 : 990 : 62 66. (Pubitemid 36808281)
186. Graves S, Unsworth N, Stenos J. Rickettsioses in Australia. Ann N Y Acad Sci 2006 : 1078 : 74 79. (Pubitemid 44968592)
187. Graves SR, Stewart L, Stenos J, et al. Spotted fever group rickettsial infection in south-eastern Australia: isolation of rickettsiae. Comp Immunol Microbiol Infect Dis 1993 : 16 : 223 233.
188. Stewart RS. Flinders Island spotted fever: a newly recognised endemic focus of tick typhus in Bass Strait. Part 1. Clinical and epidemiological features. Med J Aust 1991 : 154 : 94 99.
189. Sexton DJ, Dwyer B, Kemp R, Graves S. Spotted fever group rickettsial infections in Australia. Rev Infect Dis 1991 : 13 : 876 886.
190. Andrew R, Bonnin JM, William S. Tick typhus in north Queensland. Med J Aust 1946 : 2 : 253 258.
191. Roberts FHS. A systematic study of the Australian species of the genus Ixodes (Acarine: Ixodidae). Aust J Zool 1960 : 8 : 392 485.
192. Sexton DJ, King G, Dwyer B. Fatal Queensland tick typhus. J Infect Dis 1990 : 162 : 779 780. (Pubitemid 20266183)
193. Hudson BJ, Cottee GS, McPetrie R. Ciprofloxacin treatment for Australian spotted fever. Med J Aust 1996 : 165 : 588.
194. Fan MY, Walker DH, Yu SR, Liu QH. Epidemiology and ecology of rickettsial diseases in the People's Republic of China. Rev Infect Dis 1987 : 9 : 823 840.
195. Pretorius AM, Birtles RJ. Rickettsia aeschlimannii: A new pathogenic spotted fever group rickettsia, South Africa. Emerg Infect Dis 2002 : 8 : 874. (Pubitemid 34940538)
196. Raoult D, Fournier PE, Abboud P, Caron F. First documented human Rickettsia aeschlimannii infection. Emerg Infect Dis 2002 : 8 : 748 749. (Pubitemid 34764749)
197. Dupont HT, Cornet JP, Raoult D. Identification of rickettsiae from ticks collected in the Central African Republic using the polymerase chain reaction. Am J Trop Med Hyg 1994 : 50 : 373 380. (Pubitemid 24110490)
198. Vitale G, Mansuelo S, Rolain JM, Raoult D. Rickettsia massiliae human isolation. Emerg Infect Dis 2006 : 12 : 174 175.
199. Sarih M, Socolovschi C, Boudebouch N, Hassar M, Raoult D, Parola P. Spotted fever group rickettsiae in ticks, Morocco. Emerg Infect Dis 2008 : 14 : 1067 1073. (Pubitemid 351920436)
200. Simser JA, Palmer AT, Fingerle V, Wilske B, Kurtti TJ, Munderloh UG. Rickettsia monacensis sp. nov., a spotted fever group Rickettsia, from ticks (Ixodes ricinus) collected in a European city park. Appl Environ Microbiol 2002 : 68 : 4559 4566. (Pubitemid 34993531)
201. Jado I, Oteo JA, Aldamiz M, et al. Rickettsia monacensis and human disease, Spain. Emerg Infect Dis 2007 : 13 : 1405 1407. (Pubitemid 47510313)
202. Fournier PE, Allombert C, Supputamongkol Y, Caruso G, Brouqui P, Raoult D. Aneruptive fever associated with antibodies to Rickettsia helvetica in Europe and Thailand. J Clin Microbiol 2004 : 42 : 816 818. (Pubitemid 38222668)
203. Fournier PE, Grunnenberger F, Jaulhac B, Gastinger G, Raoult D. Evidence of Rickettsia helvetica infection in humans, eastern France. Emerg Infect Dis 2000 : 6 : 389 392. (Pubitemid 30643662)
204. Inokuma H, Takahata H, Fournier PE, et al. Tick paralysis by Ixodes holocyclus in a Japanese traveler returning from Australia associated with Rickettsia helvetica infection. J Travel Med 2003 : 10 : 61 63. (Pubitemid 36313660)
205. Nilsson K, Lindquist O, Pahlson C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet 1999 : 354 : 1169 1173. (Pubitemid 29460447)
206. Lakos A. Tick-borne lymphadenopathy - a new rickettsial disease? Lancet 1997 : 350 : 1006. (Pubitemid 27421118)
207. Raoult D, Lakos A, Fenollar F, Beytout J, Brouqui P, Fournier PE. Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clin Infect Dis 2002 : 34 : 1331 1336. (Pubitemid 34507942)
208. Mediannikov O, Matsumoto K, Samoylenko I, et al. Rickettsia raoultii sp. nov., a spotted fever group rickettsia associated with Dermacentor ticks in Europe and Russia. Int J Syst Evol Microbiol 2008 : 58 : 1635 1639.
209. Porta FS, Nieto EA, Creus BF, et al. Tick-borne lymphadenopathy: a new infectious disease in children. Pediatr Infect Dis J 2008 : 27 : 618 622.
210. Ibarra V, Portillo A, Santibanez S, et al. DEBONEL/TIBOLA: is Rickettsia slovaca the only etiological agent? Ann N Y Acad Sci 2005 : 1063 : 346 348.
211. Fournier PE, Gouriet F, Brouqui P, Lucht F, Raoult D. Lymphangitis-associated rickettsiosis, a new rickettsiosis caused by Rickettsia sibirica mongolotimonae: seven new cases and review of the literature. Clin Infect Dis 2005 : 40 : 1435 1444. (Pubitemid 40628631)
212. Tissot-Dupont H, Raoult D. Q fever. Infect Dis Clin North Am 2008 : 22 : 505 514, ix.
213. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999 : 12 : 518 553. (Pubitemid 29484745)
214. Eklund CM. A case of Q fever probably contracted by exposure to ticks in nature. Pub Health Rep 1947 : 62 : 1413 1416.
215. Raoult D. Antibiotic treatment of rickettsiosis, recent advances and current concepts. Eur J Epidemiol 1991 : 7 : 276 281.
216. Dumler JS. Q fever. Curr Treat Options Infect Dis 2002 : 4 : 437 445.
217. Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother 2001 : 45 : 3644 3646. (Pubitemid 33107898)
218. Haldane EV, Marrie TJ, Faulkner RS, Lee SH, Cooper JH, MacPherson DD, Montague TJ. Endocarditis due to Q fever in Nova Scotia: experience with five patients in 1981-1982. J Infect Dis 1983 : 148 : 978 985. (Pubitemid 14206299)
219. Turck WP, Howitt G, Turnberg LA, et al. Chronic Q fever. Q J Med 1976 : 45 : 193 217.
220. Morovic M. Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only? Am J Trop Med Hyg 2005 : 73 : 947 948. (Pubitemid 41688474)
221. Drancourt M, Raoult D, Xeridat B, Milandre L, Nesri M, Dano P. Q fever meningoencephalitis in five patients. Eur J Epidemiol 1991 : 7 : 134 138.
222. Bernit E, Pouget J, Janbon F, Dutronc H, Martinez P, Brouqui P, Raoult D. Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med 2002 : 162 : 693 700. (Pubitemid 34226397)
223. Raoult D, Houpikian P, Tissot Dupont H, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 1999 : 159 : 167 173. (Pubitemid 29055105)
224. Levy PY, Drancourt M, Etienne J, et al. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother 1991 : 35 : 533 537.
225. Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q fever: epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008 : 83 : 574 579. (Pubitemid 351717004)
226. Raoult D. Treatment of Q fever. Antimicrob Agents Chemother 1993 : 37 : 1733 1736. (Pubitemid 23265521)
227. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001 : 33 : 312 316. (Pubitemid 32664833)
228. Langley JM, Marrie TJ, Leblanc JC, Almudevar A, Resch L, Raoult D. Coxiella burnetii seropositivity in parturient women is associated with adverse pregnancy outcomes. Am J Obstet Gynecol 2003 : 189 : 228 232. (Pubitemid 36886554)
229. Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 2002 : 162 : 701 704. (Pubitemid 34226398)
230. Carcopino X, Raoult D, Bretelle F, Boubli L, Stein A. Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy. Clin Infect Dis 2007 : 45 : 548 555. (Pubitemid 47328633)
231. Swanson SJ, Neitzel D, Reed KD, Belongia EA. Coinfections acquired from ixodes ticks. Clin Microbiol Rev 2006 : 19 : 708 727. (Pubitemid 44582978)
232. Belongia EA, Reed KD, Mitchell PD, et al. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin Infect Dis 1999 : 29 : 1472 1477. (Pubitemid 30022743)
233. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol 1996 : 34 : 724 727. (Pubitemid 26065807)
234. Krause PJ, Telford SR III., Pollack RJ, et al. Babesiosis: an underdiagnosed disease of children. Pediatrics 1992 : 89 : 1045 1048.
235. Krause PJ, Telford SR III., Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. Jama 1996 : 275 : 1657 1660. (Pubitemid 26175813)
236. Benach JL, Coleman JL, Habicht GS, MacDonald A, Grunwaldt E, Giron JA. Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. J Infect Dis 1985 : 152 : 473 477. (Pubitemid 15018677)
237. Cimperman J, Maraspin V, Lotric-Furlan S, et al. Concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in patients with acute meningitis or meningoencephalitis. Infection 1998 : 26 : 160 164. (Pubitemid 28279250)
238. Sexton DJ, Corey GR, Carpenter C, et al. Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsia: a case report. Emerg Infect Dis 1998 : 4 : 311 316. (Pubitemid 28311221)
239. Bakken JS, Dumler S. Human granulocytic anaplasmosis. Infect Dis Clin North Am 2008 : 22 : 433 448, viii.